| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.50T | 4.19T | 3.52T | 1.98T | 1.60T | 1.53T |
| Gross Profit | 2.32T | 2.19T | 1.85T | 1.13T | 892.43B | 782.43B |
| EBITDA | 905.96B | 924.57B | 757.81B | 685.87B | 535.98B | 453.69B |
| Net Income | 715.38B | 673.51B | 622.66B | 495.45B | 386.00B | 325.98B |
Balance Sheet | ||||||
| Total Assets | 46.26T | 48.19T | 44.12T | 25.76T | 21.11T | 17.98T |
| Cash, Cash Equivalents and Short-Term Investments | 1.92T | 9.20T | 9.93T | 7.24T | 4.34T | 5.32T |
| Total Debt | 6.16T | 7.46T | 8.15T | 3.24T | 2.34T | 1.48T |
| Total Liabilities | 40.39T | 39.56T | 36.23T | 22.84T | 18.60T | 15.82T |
| Stockholders Equity | 5.65T | 7.68T | 6.95T | 2.91T | 2.50T | 2.16T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.13T | 968.48B | 433.58B | 554.69B | 903.97B |
| Operating Cash Flow | 0.00 | 1.20T | 1.02T | 477.20B | 581.02B | 921.78B |
| Investing Cash Flow | 0.00 | -3.72T | -3.67T | -4.39T | -3.30T | -2.52T |
| Financing Cash Flow | 0.00 | 2.42T | 3.35T | 4.17T | 2.91T | 1.92T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $96.78B | 9.08 | 21.64% | 9.77% | 11.82% | 3.41% | |
72 Outperform | $89.08B | 10.18 | 11.88% | 3.11% | 1.79% | 30.93% | |
69 Neutral | $101.24B | 18.92 | 15.95% | 0.85% | 10.85% | 7.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $135.66B | 21.06 | 13.09% | 3.03% | -1.78% | 0.65% | |
64 Neutral | $80.02B | 12.62 | 9.93% | 3.19% | -20.94% | -18.71% | |
57 Neutral | $108.75B | 10.79 | 9.73% | 2.31% | -2.84% | 25.48% |